BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Figure out How to Involve a Brain science Certification in Showcasing - 2The Best 20 Tunes that Characterized an Age
- 3Step by step instructions to Deal with Your Time While Chasing after an Internet based Degree
- 4Ergonomic Office Seats for Work spaces
- 5Kate Hudson, 46, says she doesn't need long workouts to feel good
- CDC clarifies stance on vaccines and autism, stating no evidence supports the link
- EU Council president: Ukraine should receive binding guarantees
- An Extended period of Voyaging Carefully: the World with Reason
- Figure out How to Remain Informed about the Most recent Open Record Extra Offers
- The Hybrid Volkswagen ID. ERA 9X Will Become the Brand’s New Flagship in China
- Instructions to Shield Your Gold Speculation from Possible Dangers: Fundamental Protections
- Building a Maintainable Closet: Individual Excursions in Moral Style
- The Solution to Defeating Tarrying: Systems for Expanded Efficiency
- Ukraine: Russians abduct 50 Ukrainians from border village in Sumy
